New Delhi, September 18, 2020: Last year Cadila Pharma won the CLO award at TISS and Observenow award for innovative learning initiatives. Continuing its journey of expanding digitization initiatives in the last one year Cadila Pharma has taken massive leaps in upskilling a 2,000-strong field force via digital mediums. Leaders from Cadila Pharma share their insights of the Journey and transformation.
Taking upskilling to the next level, and in what is likely to be a major milestone in its digital journey, drug major Cadila Pharmaceuticals has successfully trained its field force of more than 2,000 people via online sessions and video tutorials during the Covid-19 forced lockdown.
The New Normal and Digital Transformation
“Digital Transformation in pharmaceuticals is here to stay. Cadila Pharma embarked on this journey a year ago and had been making strides towards our efforts to enable our teams. We won the CLO award last year at Tata Institute of Social Sciences for one of our innovative learning initiatives. Digital transformation has always been a focus area for us and while we continue to work on innovations across marketing initiatives, employee engagement, and manufacturing innovations, upskilling of employees takes precedence since they are the ones who will lead change both internally as well as externally,” shared Kulwinder Singh, Chief Communication Officer, Cadila Pharmaceuticals.
When the nationwide lockdown was imposed, it limited the conventional marketing initiatives and interaction with customers, and gave rise to the challenge of strengthening the digital marketing efforts right to the last sales force team member for organizations all across.
“There are multiple new opportunities coming up along with digitization. We decided to use the opportunity to upskill our employees with the aim to help them adapt to the digitalization happening within the organization and also help drive employee engagement virtually, in the new normal in the times of Covid-19,” shares Biswajit Mitra, Chief Mentoring Officer, Cadila Pharmaceuticals.
“Pharma industry has largely been dependent on traditional marketing activities, but in the new normal, ‘smart’ brands will be the most recalled brands. I am happy to share that our teams are future-ready to take up the new challenge of digital marketing, and we are further helping them with the right tools and content to engage the customers,” added Mr O.P. Singh, President, Sales and Marketing, Cadila Pharmaceuticals
Corporate Comm India (CCI Newswire)
